Hospira Gemcitabine Injection (38 mg/mL) 2 g/52.6 mL (US)

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Saatavilla:

Hospira Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Gemcitabine hydrochloride

Lääkemuoto:

Injection, solution

Koostumus:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

Antoreitti:

Intravenous Infusion

Kpl paketissa:

1 x 52.6 mL pack

luokka:

Medicine Listed (Export Only)

Prescription tyyppi:

(S1) This Schedule is intentionally blank

Käyttöaiheet:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Tuoteyhteenveto:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2011-11-04